Loyens & Loeff assisted Alvotech’s bondholders with the upsize by USD 70 million of Alvotech’s existing senior bonds in the context of an additional USD 136 million financing facilities secured by Alvotech

Our Luxembourg team advised the bondholders’ consortium on all Luxembourg law aspects of the upsize, including the upsize documentation and related allocation of warrants (subject to conditions, as further set out in the upsize documentation).

Alvotech is a global biotech company specialising in the development and manufacture of biosimilar medicines for patients worldwide.